| Read in browser | ||||||||||||||||||||||||||||||||||||||||||||||||||
Good morning. Oil fears spur fresh selling in stocks and bonds. The Ellisons reshape Tinseltown. And brain-boosting peptides are on the rise, but at what risk? Listen to the day’s top stories. — Angela Cullen
Oil is on an upward trajectory again after the White House reportedly asked the military to draw up strike options against Iran that could be executed before November’s midterm elections. Soaring freight rates, a tanker hit off Qatar, and Hurricane Isaias taking aim at the US Gulf are adding to investors’ concerns, which sparked fresh selling in bonds and stocks. Separately, Saudi Arabia is in talks to formalize oil shuttles outside the Strait of Hormuz as it pushes for more market share. Record-setting results from Samsung and TSMC failed to excite a market that’s getting used to torrid AI growth. But there’s no letup in blockbuster deals to build out the sector. Broadcom is said to be in talks to arrange $30 billion in debt financing to help OpenAI buy custom AI chips it’s developing. And China’s Tencent is said to be mulling a $5 billion offshore bond sale. Meanwhile, the Pentagon agreed to issue a conditional loan to Wolfspeed, the chipmaker that filed for bankruptcy last year. On Wall Street, junior recruits are starting their careers managing AI agents, but where does that leave middle managers? Meanwhile, Goldman’s top brass are doing just fine, with about 20 executives in line for more than $500 million in equity awards. Donald Trump defended his immigration policies during a visit to Texas on Wednesday as he sought to boost struggling GOP Senate candidate Ken Paxton. He also wants to turn his West Palm Beach golf course into a new Camp David. The focus turns to Michigan on Thursday as Democrat Abdul El Sayed debates Republican Mike Rogers. A “wave election” could bring one-party GOP government to an abrupt halt and spell all sorts of trouble for Trump. Here’s how. Russia denied reports that a second person had fallen ill after being in contact with the employee of an anti-plague laboratory whose death has sparked international scrutiny. It previously said no traces of plague were detected in samples from the deceased worker. One of history’s most feared diseases, plague is responsible for pandemics that killed tens of millions of people. Today, human cases are rare and can usually be treated with antibiotics. Here’s what to know. Limited-time offer: 60% off unlimited access Summer's over, but the markets didn't take a break. Stay ahead with trusted business news, markets data and expert analysis. Get your first year for just Deep Dive: The Ellisons Reshape Tinseltown
David Ellison.
Photographer: Kyle Grillot/Bloomberg
Done deal. David Ellison and his family pumped in another $17 billion to get Paramount’s acquisition of Warner Bros. over the line this week. If the deal itself was anything but smooth, the even tougher task of running a media and entertainment empire now begins as fortunes change for the industry.
The Big Take
Illustration: Felix Decombat for Bloomberg
Prediction markets tout themselves as “truth machines,” but Bloomberg’s analysis of more than a billion trades shows how longshots cost customers and power the platforms. Opinion
President Trump discusses AI with Anthropic CEO Dario Amodei.
Photographer: Kevin Dietsch/Getty Images
No set of AI policies will produce perfect safety and models will surely cause further havoc, Bloomberg’s editors write. But advancing any new technology requires ambition, experimentation and risk-taking — including leaps into the unknown. Such is the price of progress. More Opinions Test Your Knowledge
Before You Go
Illustration by Ard Su
Peptides are having a moment. People are flocking to the amino acids in pursuit of sharper thinking, a competitive edge or to slow cognitive aging, often without medical supervision. A Few More More From BloombergEnjoying Morning Briefing Americas? Get more news and analysis with our regional editions for Asia and Europe. Check out these newsletters, too:
Explore all newsletters at Bloomberg.com. We’re improving your newsletter experience and we’d love your feedback. If something looks off, help us fine-tune your experience by reporting it here. Follow Us You received this message because you are subscribed to Bloomberg’s Morning Briefing Americas newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Thursday, October 8, 2026
Oil jitters return
Subscribe to:
Post Comments (Atom)
Bull market... or historic crash? 🛑
Millionaire trader reveals simple plan to make $1K in any market — ...
-
Revolutionary Stem Cell & PRP —Start Your Journey Today ...
-
You’ve shown interest in Regenerative Medicine ...




No comments:
Post a Comment